Informations techniques
Exploitant
LUPIN EUROPE GmbH
Présentation
NAMUSCLA 167 mg, gélule
B/30 (CIP : 34009 301 721 2 4)
B/50 (CIP : 34009 301 721 3 1)
B/100 (CIP : 34009 301 721 4 8)
B/200 (CIP : 34009 550 625 8 5)
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
vhSJNuLSnZmDt4cT